144 related articles for article (PubMed ID: 37165798)
21. Thiazolyl-isatin derivatives: Synthesis, in silico studies, in vitro biological profile against breast cancer cells, mRNA expression, P-gp modulation, and interactions of Akt2 and VIM proteins.
Freitas LAB; Sousa C; Lima BS; Duarte D; Gomes PATM; Ramos CGC; Costa VCM; Pitta MGDR; Rêgo MJBM; de Simone CA; Videira M; Leite ACL
Chem Biol Interact; 2024 May; 394():110954. PubMed ID: 38518852
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
23. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of Tamoxifen-Artemisinin and Estrogen-Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer.
Fröhlich T; Mai C; Bogautdinov RP; Morozkina SN; Shavva AG; Friedrich O; Gilbert DF; Tsogoeva SB
ChemMedChem; 2020 Aug; 15(15):1473-1479. PubMed ID: 32374071
[TBL] [Abstract][Full Text] [Related]
25. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
26. Development and evaluation of novel artemisinin-isatin hybrids with potential anti-leukemic cytotoxicity.
Wang P; Zhang Z; Cao W; Zhang X
Front Oncol; 2023; 13():1112369. PubMed ID: 37124527
[TBL] [Abstract][Full Text] [Related]
27. Antiproliferative Phenothiazine Hybrids as Novel Apoptosis Inducers against MCF-7 Breast Cancer.
Zhang JX; Guo JM; Zhang TT; Lin HJ; Qi NS; Li ZG; Zhou JC; Zhang ZZ
Molecules; 2018 May; 23(6):. PubMed ID: 29843370
[TBL] [Abstract][Full Text] [Related]
28. Design, Synthesis and Anti-Lung Cancer Evaluation of 1, 2, 3-Triazole Tethered Dihydroartemisinin-Isatin Hybrids.
Hou H; Qu B; Su C; Hou G; Gao F
Front Pharmacol; 2021; 12():801580. PubMed ID: 34975498
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies.
El-Azab AS; Al-Dhfyan A; Abdel-Aziz AA; Abou-Zeid LA; Alkahtani HM; Al-Obaid AM; Al-Gendy MA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):935-944. PubMed ID: 28718672
[TBL] [Abstract][Full Text] [Related]
30. Fe3O4 Nanoparticles Mediated Synthesis of Novel Isatin-dihydropyrimidinone Hybrid Molecules as Antioxidant and Cytotoxic Agents.
Maddela S; Makula A; Jayarambabu N
Anticancer Agents Med Chem; 2017; 17(3):456-463. PubMed ID: 27173964
[TBL] [Abstract][Full Text] [Related]
31. Antiproliferative activity, enzymatic inhibition and apoptosis-promoting effects of benzoxazole-based hybrids on human breast cancer cells.
Omar AME; AboulWafa OM; Amr ME; El-Shoukrofy MS
Bioorg Chem; 2021 Apr; 109():104752. PubMed ID: 33657444
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of novel isatin-thiazoline and isatin-benzimidazole conjugates as anti-breast cancer agents.
Taher AT; Khalil NA; Ahmed EM
Arch Pharm Res; 2011 Oct; 34(10):1615-21. PubMed ID: 22076761
[TBL] [Abstract][Full Text] [Related]
33. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
[TBL] [Abstract][Full Text] [Related]
34. Azide-Alkyne Cycloaddition En Route to 1
Singh A; Saha ST; Perumal S; Kaur M; Kumar V
ACS Omega; 2018 Jan; 3(1):1263-1268. PubMed ID: 30023800
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
[TBL] [Abstract][Full Text] [Related]
36. Three-Carbon Linked Dihydroartemisinin-Isatin Hybrids: Design, Synthesis and Their Antiproliferative Anticancer Activity.
Dong M; Zheng G; Gao F; Li M; Zhong C
Front Pharmacol; 2022; 13():834317. PubMed ID: 35153798
[TBL] [Abstract][Full Text] [Related]
37. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
[TBL] [Abstract][Full Text] [Related]
38.
Zegheb N; Boubekri C; Lanez T; Lanez E; Küçükkılınç TT; Öz E; Khennoufa A; Khamouli S; Belaidi S
Anticancer Agents Med Chem; 2022; 22(7):1426-1437. PubMed ID: 34170810
[TBL] [Abstract][Full Text] [Related]
39. Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study.
Salem MG; El-Maaty DMA; El-Deen YIM; Elesawy BH; Askary AE; Saleh A; Saied EM; Behery ME
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956848
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents.
Eldehna WM; Almahli H; Al-Ansary GH; Ghabbour HA; Aly MH; Ismael OE; Al-Dhfyan A; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):600-613. PubMed ID: 28173708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
